LY-2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC₅₀ of 2 nM and 10 nM, respectively. LY-2835219 inhibits the p roliferation of Rb-positive tumor cells and demonstrates dose-dependent growth inhibition in ER+ breast cancer models

Numéro d'article : BIOVB1039-10

Unité de mesure : 10 MG

158.00 CHF 158.0 CHF 158.00 CHF

158.00 CHF

Cette combinaison n'existe pas.

AJOUTER AU PANIER

Délai de livraison actuel sur demande

Numéro CAS : 1231930-82-7

Fabricant : BIOVISION

Numéro du fabricant : B1039-10

Formule chimique : C27H32F2N8.CH4O3S

Température de stockage : Freezer (-20)

LY-2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC₅₀ of 2 nM and 10 nM, respectively. LY-2835219 inhibits the p roliferation of Rb-positive tumor cells and demonstrates dose-dependent growth inhibition in ER+ breast cancer models

LY-2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC₅₀ of 2 nM and 10 nM, respectively. LY-2835219 inhibits the p roliferation of Rb-positive tumor cells and demonstrates dose-dependent growth inhibition in ER+ breast cancer models

158.00 CHF 158.0 CHF 158.00 CHF

158.00 CHF

Not Available For Sale